General impressions
In some places the treatment of gonorrhoea is still divorced from that of syphilis, the latter disease being treated in dermatological clinics and the former in urology centres (as in the Hospital of the University of Pennsylvania). In other places, such as the Johns Hopkins Hospital, Baltimore, both diseases are treated together. In municipal health centres and venereal diseases clinics, patients with both disorders are seen in the first place (as in New York and Chicago), but whereas gonorrhoea is dealt with in the clinics, patients with syphilis are transferred to the United States Public Health Rapid Treatment Centre for in-patient penicillin treatment. Patients with soft sore (chancroid), lymphogranuloma inguinale and granuloma venereum tend to be grouped with those having syphilis, whereas patients with semi-venereal conditions (non-specific urethritis, penile warts and so forth) are frequently referred to the urological or surgical departments. Venereal disease-or at any rate syphilis-is usually notifiable to the city health departments, which undertake also the "chasing" of contacts. Repeated letters, registered letters, telegrams and special visitors are all used to bring the patients in. Propaganda is much in evidence; most of the trams in Chicago, for example, carry venereal disease placards, and press and radio are also employed. Matches, too, which are given away free with cigarettes in the United States, are used in this way. Defaulters are usually contacted in the first instance by the clinic concerned. One (Belle Vue Hospital, New York) relies on a battery of letters in recalcitrant cases; these are sent simultaneously to the patient, his home, his work, his trade union and his known relatives. Many clinics never discharge a syphilitic patient. Patients who refuse to attend may be compelled to do so, ultimately, by the City Health Department. Venereal disease control officers have large staffs dealing with notification and defaulter contact tracing. Chicago, which undertakes more propaganda than do most places, keeps an eye open for sources of infection, and if a particular bar or hotel is suspected of being a hotbed of disease, the proprietor is visited and asked to mend his ways. If he fails to cooperate, his business -may be closed by the -Health Department, and notices such as "Venereal Disease: Beware" and "Syphilis: Keep Out" may be plastered on his premises. This has been done only a few times; hotel keepers usually cooperate.
Gonorrhoea
It was an often-expressed view that "gonorrhoea was beaten " and, although there were isolated voices urging maintained caution, there was an increasing tendency to relax the severity of the tests of cure of the disease.
TREATMENT OF VENEREAL DISEASE IN TIE UNITED STATES
Treatment.-Treatment was with aqueous penicillin, or with penicillin given in oil and beeswax or by other delaying methods, usually on an ambulatory basis. The dosage employed in the 6 clinics visited which treated gonorrhoea was, with one exception, 200,000 units; in the exceptional case it was 300,000 units. Three of the clinics used the aqueous solution, the dosage consisting of 4-5 doses at 2-3 hours' intervals to a total of 200,000 units. Two others used penicillin in beeswax in single doses of 200,000 and 300,000 units, and one gave 200,000 units of calcium penicillin in a cholesterol preparation in peanut oil (arachis oil). Excellent results were claimed with all the methods employed.
Tests of cure (males).-Tests of cure were generally made early. The, Army had its men seen once a week, for inspection, for 3 weeks only, and a final Kahn test only is done at the end of 3 months. At the Johns Hopkins Clinic male patients attended once a week for 3 weeks for prostatic massage and urine culture, after which time they were seen once a month for 4 months for blood tests, in order to exclude syphilis. Other clinics reduced their-tests still further, doing a culture at the end of 24 hours and repeating it at the end of 5 and 10 days, whereas in a very large out-patient clinic in Chicago, which was using penicillin in oil and beeswax, a prostatic massage and culture were done after 3 days and were followe.d by a blood test only, once a month for 3 months. At the Walter Reed Hospital, Washington, where Romansky's oil-beeswax penicillin was in use, 300,000 units were given, and the patients were watched without laboratory tests for one week. At the United States Marine Hospital, Staten Island (N.Y.), Dr. J. F. Mahoney gave 200,000 units of aqueous solution in 5 doses and, apart from an instrucfion to the men-to obtain a blood test at the end of 3 months, there was no provision at all for tests of cure. This procedure was based on a large-scale investigation, consisting of culture on alternate days for 3 weeks, in which the number of failures had proved to be negligible in relation to the large numbers treated. Some 400 men are being treated each month by this method. In the Canadian Army in Canada, 200,000 units of penicillin in an aqueous solution, given in 4 doses, was the treatment; inspections were made 3 times in the first 2 weeks and followed by a blood test at the end of 3 months.
Tests of cure (females).-Greater caution is being observed with females, with general examination of the order of once a month for 3 months, although, at the very large clinic in Chicago, cultures and smears after 3 days constituted the only follow-up, apart from monthly blood tests for 3 months in satisfactory cases. The principle of treating clinically doubtful or even negative female contacts of infected men, on epidemiological grounds, was adopted largely.
Research.-Dr. Mahoney described his work with 300 prisoner volunteers, in whom he instilled, per urethrum, strains of gonococci. Only 30 per cent became infected. At most of the centres which I visited some small-scale experiments of between 20 and 30 cases had been treated experimentally with penicillin orally. All the investigators seem to have been satisfied that such therapy was possible and not to have pursued the matter farther.
Syphilis
The current views on the treatment of syphilis were expressed at the United States Public Health Service and National Research Council meeting held at Washington on 7th and 8th February, at which Dr. J. E. Moore presided.
If the conclusions reached appear to be uncrystallized, it is because, for some\ years now, most of the leading clinics have been participating in a nation-wide research into the action of pencillin on syphilis and this work is still very far from, complete. This research, which was taken over in 1946 follows.
(1) Total dosage. The cumulative proportion of failure at 11 months varied from 15 per cent (2,400,000 units) to 62 per cent with 60,000 units of penicillin.
(2) Combined treatment: (a) Penicillin and arsenic.-The cumulative percentage of failure at the end of 11 months with a total dose of 300,000 units of penicillin was twice as great when it was given alone as when it was given in combination with 320 milligrams of arsenoxide (42 per cent versus 21 per cent). The combined dose gave the same results as did penicillin alone at a total dosage of 1,200,000 units. (b) Penicillin and bismuth.-The failure rate at 160 days With 1,200,000 units of penicillin alone was 10 per cent, which was reduced to 6 per cent when 1 gramme of bismuth was added.
(3) Intervals between injections and the duration of treatment.-There was no evidence of a sizable difference, according to whether the interval between injections was 3 hours or 6 hours, or whether the duration of treatment was 4 days or 71 days. There was a slight difference in favour of 3'hours rather than 6 in a course of treatment of 7T days.
(4) Duration of disease.-For long duration of the disease the failure rate was higher than for short duration. For duration of 2 months or more, the failure rate at the end of 11 months was more than twice that of cases treated in the first week of the disease (32 per cent against 14 per cent).
-(-5) Colour and sex.-There was no difference in results between white and coloured races at the end of 11 months. The female failure rate was slightly higher than the male.
(6) Re-treatment.-Patients re-treated because of clincal failure showed a higher cumulative percentage failure rate by the end of 7 months than did those with previously untreated early secondary syphilis receiving the same dosage of penicillin. An interesting chart was presented showing the results in the United States Public Health Service Clinics, and comparing those given by the use of 2,400,000 Units of penicillin alone with those from one-day fever and arsenic, with 5 days' and 8 days' intravenous drip arsenic, and with the Eagle 12-weeks' system of arsenic and bismuth. The failure rates at 11 months were as follows. Penicillin alone.-The United States Army had used 2,400,000 units over 71 days. Lt.-Col. Sternberg was satisfied with this as a treatment and gave details of 1,107 patients treated. About one-third of the number had been followed up for over a year. Seronegative primary cases produced 5 28 per cent of failures, seropositive primary cases 9 54 per cent and secondary cases 17 4 per cent of failures in that time. In only 9 per cent was the treatment considered to be actually unsatisfactory.
Penicillin and arsenoxide.-Dr. Evan Thomas of New York had treated 1,119 patients with 1,200,000 units of penicillin given 3-hourly over 7J days plus 0-04 gramme of Mapharsen daily for 8 days. Of 611 patients followed up, there was a failure rate of 12 per cent at 6 months. With 1,200,000 units only there was a failure rate of 17-6 per cent in 556 cases followed up for the same time.
Penicillin plus bismuth.-Dr. Schoch (Dallas) had treated 291 cases with 1,200,000 units cf penicillin over 7A days plus 1 gramme of bismuth subsalicylate in oil. The failure rate at 160 days was 6 per cent, as compared with 10 per cent in cases in which the same dose of pencillin alone was given.
Penicillin plus fever.-Dr. G. X. Schwemlein (Chicago) described his results with 108 patients treated with 1,200,000 units of penicillin over 71 days plus a three-hours'-fever session of 106°F (rectal), administered by the use of the hypertherm, on the second, fourth and sixth days. The patients were observed for 154-353 days and there has been a 14-7
per cent failure rate to date. A further 2C2 patients were given a two-days' treatment, 600,000 units of penicillin being given in two-hourly doses of 50,000 units each on the first day, followed bv a six-hours' fever session, during which a further 6C0,000 units were given in hourly doses of 100,000 units. The patients had been observed for 153-361 days and 19-3 per cent of failures had occurred up to the time of reporting. Penicillin in oil and beeswax.-Capt. Romansky had treated 68 cases of early syphilis with 8 single daily injections of 300,000 units. Only 22 had been followed up for over 6 months and there had been 2 failures. Major Leifer had treated 200 army cases on the same regimen. He had had 5 instances of secondary fever, 4 of urticaria, 2 of herpes simplex and 2 of disseminated macular eruption on the ninth day. Only 10 of this series had been followed up for over 6 months, and therefore no definite conclusions were drawn.
Technique of treatment with penicillin in oil and wax.-Penicillin in arachis oil and beeswax, which is featured considerably in the new treatment schedules in an attempt to -evolve a satisfactory treatment for ambulatory cases, besides being made locally in some centres, is also being made by two commercial houses to the Romansky formula. One of them supplies enough for a single dose in an expendable plastic syringe.
Romansky used calcium penicillin of a potency of 1,000 units per milligram (Romansky and Rittman). He found that sodium penicillin gave unreliable blood levels and also that sodium preparations deteriorated more rapidly than did the calcium salt. The penicillin must be powdered dry, and anhydrous peanut (arachis) oil and sunbleached beeswax must be used. The most effective combination that he had found contained 300,000 units of calcium penicillin in 4-8 per cent beeswax. (by weight) in arachis oil to each 1 cubic centimetre. Patients who received a single injection of 1 cubic centimetre of this preparation all had assayable levels of penicillin in the blood at 12-16 hours, 84 per cent at 20 hours and 70 per cent at 24 hours after the injection. The preparation maintained its potency for over a year at room temperature and refrigerator temperatures. There was no loss at 56°C until 24-36 hours and even at 1000C there was no loss for 2 hours. In giving the injection absolute dryness was essential, as moisture caused this preparation to stick in the needle.
At the Walter Reed General Hospital, Washington (D.C.), a vacuum autoclave was used for syringe sterilization, but when this was not available the washing through of the sterilized syringe with alcohol and ether was considered to be sufficient. The preparation should be warmed under the tap or on the sterilizer before use, and 2 different needles should be employed, one for extracting the solution and another for giving the injection. Luer Lock syringes were used. At the Walter Reed Hospital, some 25,000 of these injections had been given in 5 months by nurses. Romansky said that he had no doubt as to the preparation being easy to administer. Other doctors, however, from widely separated areas, had a different opinion on this point. The differences probably arose because the Romansky formula was not being used by them, or, if it was, a dry sterilization technique was not being employed. In Romansky's experience, penicillin in arachis oil, given once each day, produced as satisfactory results with syphilis as did aqueous penicillin in round-the-clock administration. Some evanescent local reactions were noted, but allergic manifestations were not more frequent, in his view, than with the aqueous solution. He had noted that patients suffering from a concomitant epidermophytosis were apt to get a general itching and vesicles of the hands. A new anti-histamine preparation, Benadryl, was being studied here and elsewhere in regard to its apparently favourable effect upon allergic manifestations of penicillin therapy. The new schedules formulated for future study by the Advisory Committee reflect the present trend of ideas. The smaller dosage levels and time durations up to a week were considered as having been explored. Two exceptions were made: a combination of 2,400,000 units of penicillin with 320 milligrams of Mapharsen plus 0-6 grammes of bismuth,-given over 8 days, was recommended for one schedule, whereas personnel of the Army and the Navy were to be given 2,400,000 units of penicillin plus 1 gramme of bismuth, spread over 9 days. Both of these are intended to contrast with previous schedules without"the addition of bismuth. The other 3 schedules for the administration of penicillin in aqueous solution were of 2,400,000 units of penicillin, 9,600,000 units, and 2,400,000 units plus 480 milligrams of Mapharsen and 1 gramme of bismuth, respectively, spread over 15 days. Thus higher dosages, longer duration of treatment and combination with other medicaments are all being tried in order to improve the figures which have been presented. In addition, 3 schedules of penicillin in oil and wax were also recommended: 4,800,000 units in single daily injections, for 8 days; 9,600,000 units in single daily injections for 16 days and 9,600,000 units given in 16 injections twice weekly. All injections are to be of 600,000 units each.
Six other schedules were announced for United States Public Health Centres outside the above scheme, and-these show similar trends. Of the 3 schedules for administering aqueous penicillin, all are for dosages of 2,800,000 units of penicillin spread over 14 days: one f6r penicillin alone, one with 5 injections of Mapharsen and one with 3 injections of bismuth in addition. Of the 3 schedules for penicillin in oil and wax, all have a single daily injection of 300,000 units for 14 days' (4,200,000 units in all), whereas one has in addition 5 injections of Mapharsen and the other 3 injections of bismuth. On the face of it, it would appear that the latter group is nearer success in its attempts to produce a clear-cut result. It should be remembered, however, -that the schedules of the first group are a continuation of those which have comprised the work so far presented, and are therefore to be judged only as part of a whole.
Experimental rabbit syphilis.-Several speakers dealt with experiments with penicillin in rabbit syphilis.
Dr. R. C. Arnold (New York) showed the results of increasing dosages of penicillin given over decreasing periods of time in rabbit syphilis. He concluded that rabbit syphilis could be cured in 12 hours or less, and that additional studies should be undertaken with the object of intensifying and shortening the treatment of the syphilitic patient.
Dr. H. Eagle, however, took the opposite view, He considered that, when dealing with human material, the intensification of the dose was a waste of pencillin, as the surplus would only be thrown away. He stated that arsenic combined with the spirochaete and was, indeed, concentrated many times within it ; therefore its effects were felt for some considerable time after the injection was given. Penicillin, on the other hand, was effective only whilst it was present in the surrounding fluid; therefore, producing a supereffective concentration of penicillin over a short time (which would be done by increasing the dose) would not be as useful as increasing the duration of an already effective level, by repeating the penicillin dose after an interval.
Dr. Eagle showed (as he had already demonstrated in published work (Eagle, Magnuson and Fleischman)) that penicillin and Mapharsen were synergistic in rabbits and that the amount of penicillin required to cure rabbit syphilis was reduced to a fraction when subcurative doses of Mapharsen were added ; consequently, if the penicillin and bismuth were to prove to be similarly synergistic, the optimum therapy for human syphilis might well consist of penicillin, bismuth and Mapharsen.
Dr. C. M. Carpenter, working on penicillin and fever in rabbit syphilis, found much better results when he used fever combined with multiple rather than with single injections of penicillin; he concluded that the results of penicillin and fever were additive rather than synergistic.
Other research.-In another field Dr. Mahoney (New York), speaking about persistent positive serological reactions without clinical or case-history evidence of syphilis, said that, group.bmj.com on November 6, 2017 -Published by http://sti.bmj.com/ Downloaded from with the exception of pregnant women, patients should not be treated on the basis of serology alone. He believed that soon the new cardiolipid antigen would be available, and that this would change the whole field of serology. With his own patients Dr. Mahoney employed a battery of serological tests in syphilitic cases. A new nomenclature for an improved Lange test was also under preliminary trial in New York. The highest reading in this for a given tube was 18 instead of 5, as hitherto, and results might be compared by adding the totals.
Treatment of contacts
An interesting discussion was started at the Bethesda meeting on the question of whether clinically negative contacts of cases of dark-ground-positive cases of syphilis should or should not be treated in the absence of signs of infection. The suggestion to give this treatment received a surprising amount of support, some 50 per cent of those present being in favour; Dr. Evan Thomas had already treated over 50 such cases. He regarded such treatment as necessary for the prevention of "ping-pong" syphilis.
Tertiary syphilis
Neurosyphilis.-In the field of late syphilis the spirit of research and experimentation is also very evident. The schedules of treatment, however, have not been standardized, and opinions expresssed about the efficacy of penicillin varied. Fever therapy was still employed in many places . at Chicago, for example, neurosyphilis was treated with 12 fever-cabinet sessions, 3 a week for 4 weeks, with 60 milligrams of Mapharsen administered at the height of each fever and 200 milligrams of bismuth given for 4 injections, 1 each week, over the same period. In Philadelphia penicillin was used without pyretotherapy in doses of 4,800,000 units or less, whereas at the Belle Vue Hospital (New York) 6,000,000 units were given in 150 three-hourly injections; if re-treatment was considered necessary, this dosage was increased to 8,000,000-9,000,000 units in two-hourly doses. At the Johns Hopkins Hospital, Baltimore, 10,000,000-20,000,000 units were being used in 200 three-hourly injections spread over 25 days. It was the general policy to start immediately with the maximum dose, and although no unusual reactions were noted as the result of this, one reporting centre did state that it was common for paranoid reactions to develop in paresis cases, the exciting factor usually being the hospital "loud speaker".
At the Washington meeting Dr. J. H. Stokes gave details of 197 of a large group of cases which he had kept under observation for more than 120 days.
Treatment was confined to penicillin in dosage levels of 1,200,000-4,800,000 units and 4,800,000-10,000,000 units, given by round-the-clock administration in three-hourly intramuscular injections. He found little difference between the two dosage ranges, and said that the most striking signs of improvement were to be found in the cerebrospinal fluid findings, in which they had been consistent, prolonged and progressive. The most obvious changes were found in the first 120 days, but they might continue well after that time Out of 51 tabetics, 44 (Half a course of malaria was 4-6 paroxyms of fever, and half a course of fever consisted of 20 hours of fever above 105°F. in the fever cabinet.) Penicillin was given in 6 schedules of 3,000,000-18,000,000 in 5-45 days. Clinical improvement was very noticeable with penicillin and malaria (61 per cent) and with penicillin and fever (56 per cent), whereas with penicillin only it was seen in 41 per cent of the cases.
Dr. W. E. Graham, of Hot Springs, reviewed 83 cases observed over 3 months and treated with 6,000,000 units of oil-beeswax penicillin, patients being given 400,000 units daily for 15 days in conjunction with 8 alternate daily injections of 0-04-006 gramme of Mapharsen plus 0-2 gramme of bismuth every third day for 5 injections. His conclusion was that the clinical and laboratory findings of this treatment at the end of 3 months were comparable with those obtained after fever therapy at the end of 6 months, and that such combined therapy might well replace malaria and fever therapy entirely in the treatment ofneurosyphilis.
In contrast with these encouraging reports, Dr. R. R. Kierland, of the Mayo Clinic, described 42 cases treated with up to 16,000,000 units, some with fever therapy in addition. He concluded that in neurosyphilis penicillin did not achieve the results which it gave in the other forms of the disease ; penicillin alone was inferior to penicillin and fever, and when it was given with malaria the results were better than with fever alone. Penicillin was of no value in the "burned-out" tabetic, and patients who had had much treatment with arsenic and bismuth obtained little further benefit from penicillin.
Other forms of tertiary syphilis 'Little was said concerning other forms of late syphilis, although this was a big problem in the South. In a recent blood-testing survey in Savannah (Georgia), when over 71,000 blood tests were taken in a population of 125,000, some 18 per cent had a positive blood test, due in a large proportion of cases to latent syphilis.
Dr. W. J. Brown, when approached as to the disposal of these cases, had decided, in spite of possible dangers from cardiovascular syphilis, that all suitable patients should be admitted for intensive treatment up to the age of 45 years. No serious reactions were encountered. Cardiovascular syphilis has not come under the light of as intensive an examination as have the other forms which have been mentioned. It had formerly been the practice to treat these cardiovascular lesions with pencillin, starting with the maximum dose. A few mishaps have produced caution, and now the initial dose in cases of angina sometimes is as low as 500 units. Discussion -Before concluding these remarks on the present trends of venereal disease treatment in the United States of America, I should like to single out a few points for special discussion. First, in gonorrhoea, the dosage of penicillin employed is higher, on the whole, than that which is generally used here; secondly, the tests of cure are less stringent and the bugbear of masked syphilis is not taken too seriously, in relation either to the initial dose of penicillin employed or to the length of the follow-up period. It would be interesting to collect the views of British venereologists on these points, especially as to how many cases have been seen by them in which syphilis has developed in a patient who has received penicillin treatment for gonorrhoea and in which it has taken longer than 3 months to declare itself. Much that has been said concerning the penicillin treatment of syphilis represents British views also. Perhaps the most controversial subject is that of the treatment of the apparently non-infected paramours.
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Since the above address was given, many articles written by the authorities quoted have appeared in successive numbers of the Journal of the American Medical Association, culminating in the issue of 25th May 1946. This latter, however, contained some new and startling information, which, it is felt, must of necessity appear here (Committee on Medical Research).
In this issue appeared a most important joint statement, entitled "The Changing Character of Commercial Penicillin"', by the Committee on Medical Research, United States Health Service and Food and Drug Administration.
